EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Anlotinib Metabolic Stability in HLMs Matrix Applying Ultra‐Fast UPLC–MS/MS Approach: Greenness Assessment With In Silico Testing for Structural Alarms Related to the Metabolic Lability and DEREK Toxicity

Mohamed W Attwa iD, Ali S Abdelhameed iD, Adnan A Kadi

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Mohamed W Attwa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Microsomes, Liver, Indoles, Quinolines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: The Ongoing Research Funding program at King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anlotinib (Focus V) is approved by the China Centre for Drug Evaluation in 2018 as a third‐line treatment for patients with certain advanced cancers. This study aimed to develop a specific, fast, reliable, and sustainable ultraperformance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) approach for estimating anlotinib (ANB) in the human liver microsomes (HLMs) matrix, with the application for the assessment of ANB metabolic stability. The validation processes for the UPLC–MS/MS system complied with US Food and Drug Administration regulations following bioanalytical method validation. The established approach was validated using the HLMs matrix over the range of 1.0 to 4000 ng mL −1 within 1 min. The precision (%RSD) and accuracy (%E) rates for intra‐day and inter‐day measurements ranged from −6.33% to 4.91% and −6.67% to 5.26%, respectively. The StarDrop software package involved P450 and Deductive Estimation of Risk from Existing Knowledge modules that were applied for assessing metabolic lability and characterizing ANB structural alarms, respectively. The in vitro half‐life ( t ½ ) was computed at 44.72 min, while the clearance intrinsic (Cl int ) of ANB was calculated at 18.13 mL min −1 kg −1 . In silico evaluations suggest that minor structural alterations to the methyl group (62%), amine group (37%), and methoxy group (1%) in drug design may increase the ANB metabolic stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryMicrosomes, LiverIndolesQuinolinesHumansChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsComputer SimulationDrug StabilityLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

DEREK moduleP450 metabolic softwareStarDrop software packageUPLC–MS/MSanlotinibin vitro metabolic stability

Substanzen

IndolesQuinolinesanlotinib

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Mohamed W Attwa, Ali S Abdelhameed

Förderung

  • The Ongoing Research Funding program at King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Attwa, M. W., Abdelhameed, A. S., & Kadi, A. A. (2025). Evaluation of Anlotinib Metabolic Stability in HLMs Matrix Applying Ultra‐Fast UPLC–MS/MS Approach: Greenness Assessment With In Silico Testing for Structural Alarms Related to the Metabolic Lability and DEREK Toxicity. Biomedical Chromatography. https://doi.org/10.1002/bmc.70231

Vancouver

Attwa MW, Abdelhameed AS, Kadi AA. Evaluation of Anlotinib Metabolic Stability in HLMs Matrix Applying Ultra‐Fast UPLC–MS/MS Approach: Greenness Assessment With In Silico Testing for Structural Alarms Related to the Metabolic Lability and DEREK Toxicity. Biomedical Chromatography. 2025. doi:10.1002/bmc.70231

BibTeX
@article{Attwa2025,
  author = {Attwa, Mohamed W and Abdelhameed, Ali S and Kadi, Adnan A},
  title = {Evaluation of Anlotinib Metabolic Stability in HLMs Matrix Applying Ultra‐Fast UPLC–MS/MS Approach: Greenness Assessment With In Silico Testing for Structural Alarms Related to the Metabolic Lability and DEREK Toxicity},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70231}
}
Kostenlos starten →